Description
Immunoassay for the qualitative determination of CMV IgG avidity.
Elecsys® CMV IgG Avidity
Immunoassay for the qualitative determination of CMV IgG avidity.
-
Elecsys® HE4 – Human epididymal protein 4
A biomarker for the management of ovarian cancer patients -
Elecsys® CA 125 II
The Roche Elecsys® CA 125 II assay is a tumour marker test for use with blood samples to support monitoring and surveillance of ovarian cancer patients and together with HE 4 for risk assessment of patients with pelvic mass with the ROMA™ algorithm -
Elecsys® Syphilis
Immunoassay for the qualitative determination of total antibodies against Treponema pallidum.
Reviews
There are no reviews yet.